This case study explores the efficacy of Murchita Tila Taila Matra Basti in managing Kashtartava (primary dysmenorrhea), with modern correlation to primary dysmenorrhea and dyspareunia. The condition, affecting 45–93% of menstruating women globally, is linked to Apana Vata dysfunction. A 28-year-old woman presenting with Kashtartava and dyspareunia was treated with three consecutive cycles of Murchita Tila Taila Matra Basti. Notable improvements in pain, mood, and overall reproductive health were observed. Remarkably, the patient conceived naturally following the therapy.
Dr. Ashvini Magar* (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: